Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1969 1
1970 4
1971 4
1972 3
1973 1
1974 2
1975 4
1976 5
1977 5
1978 2
1979 4
1980 6
1981 6
1982 10
1983 13
1984 12
1985 8
1986 11
1987 8
1988 5
1989 12
1990 15
1991 9
1992 9
1993 12
1994 14
1995 17
1996 8
1997 10
1998 11
1999 14
2000 21
2001 15
2002 22
2003 27
2004 21
2005 31
2006 26
2007 23
2008 30
2009 50
2010 31
2011 40
2012 62
2013 64
2014 69
2015 64
2016 83
2017 73
2018 65
2019 71
2020 70
2021 103
2022 85
2023 68
2024 62
2025 58

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,400 results

Results by year

Filters applied: . Clear all
Page 1
Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial.
Trigo J, Subbiah V, Besse B, Moreno V, López R, Sala MA, Peters S, Ponce S, Fernández C, Alfaro V, Gómez J, Kahatt C, Zeaiter A, Zaman K, Boni V, Arrondeau J, Martínez M, Delord JP, Awada A, Kristeleit R, Olmedo ME, Wannesson L, Valdivia J, Rubio MJ, Anton A, Sarantopoulos J, Chawla SP, Mosquera-Martinez J, D'Arcangelo M, Santoro A, Villalobos VM, Sands J, Paz-Ares L. Trigo J, et al. Among authors: sala ma. Lancet Oncol. 2020 May;21(5):645-654. doi: 10.1016/S1470-2045(20)30068-1. Epub 2020 Mar 27. Lancet Oncol. 2020. PMID: 32224306 Clinical Trial.
Antiviral Peptides as Anti-Influenza Agents.
Agamennone M, Fantacuzzi M, Vivenzio G, Scala MC, Campiglia P, Superti F, Sala M. Agamennone M, et al. Among authors: sala m. Int J Mol Sci. 2022 Sep 28;23(19):11433. doi: 10.3390/ijms231911433. Int J Mol Sci. 2022. PMID: 36232735 Free PMC article. Review.
The Psychological Benefits of Cosmetic Surgery.
Kam O, Na S, La Sala M, Tejeda CI, Koola MM. Kam O, et al. Among authors: la sala m. J Nerv Ment Dis. 2022 Jul 1;210(7):479-485. doi: 10.1097/NMD.0000000000001477. J Nerv Ment Dis. 2022. PMID: 35766540 Review.
Dietary patterns and accelerated multimorbidity in older adults.
Abbad-Gomez D, Carballo-Casla A, Beridze G, Lopez-Garcia E, Rodríguez-Artalejo F, Sala M, Comas M, Vetrano DL, Calderón-Larrañaga A. Abbad-Gomez D, et al. Among authors: sala m. Nat Aging. 2025 Aug;5(8):1481-1490. doi: 10.1038/s43587-025-00929-8. Epub 2025 Jul 28. Nat Aging. 2025. PMID: 40721973 Free PMC article.
ctDNA Dynamics and Mechanisms of Acquired Resistance in Patients Treated with Osimertinib with or without Bevacizumab from the Randomized Phase II ETOP-BOOSTER Trial.
Soo RA, Dafni U, Han JY, Cho BC, Nadal E, Yeo CM, Carcereny E, de Castro J, Sala MA, Coate L, Provencio M, Britschgi C, Vagenknecht P, Dimopoulou G, Kammler R, Finn SP, Peters S, Stahel RA; ETOP 10-16 BOOSTER Collaborators. Soo RA, et al. Among authors: sala ma. Clin Cancer Res. 2024 Nov 15;30(22):5180-5191. doi: 10.1158/1078-0432.CCR-24-0932. Clin Cancer Res. 2024. PMID: 39250635 Clinical Trial.
Evolving epidemiology of HCC in Spain.
Sala M, Pascual S, Rota Roca MR, Matilla AM, Campos M, Delgado M, Ferrer MT, Montero JL, González-Santiago JM, Guerrero A, Aracil C, Rodríguez-Lope C, Romero-Gutiérrez M, Sogbe M, Vázquez-Rodríguez S, Olmo JF, Mínguez B, Cortés-García L, Vallejo-Senra N, Unceta PR, Clos A, Díaz-Bethencourt D, Sánchez AG, Castro RQ, Bustamante J, Perelló C, Urquijo Ponce JJ, Serra HA, Llamoza-Torres CJ, Montoliu S, Fernández-Marcos C, Guiberteau A, Hernández-Guerra M, Vergara M, Fernández-López AM, Valer López-Fando MP, Gutiérrez-García ML, Hernáez-Alsina T, Coll S, Cuyás B, Morillas MJ, Olmedo SR, Fernández-Bermejo M, Roget M, Ramos IC, Pacheco Del Río G, Rifà R, Gacho PC, Barrio ML, Gómez-Rubio M, Peñas I, Serra I, Cachero A, Reig M, Giraldez Á, Guerrero M, Segarra JX, Lledó JL, Díaz-González Á, Delgado C, Iñarrairaegui M, Rodríguez-González MM, Lázaro M, Bermúdez-Ramos M, Lué A, Molina E, Macías-Rodríguez MA, Rodríguez M, Chiminazzo V, Varela M. Sala M, et al. JHEP Rep. 2025 Jan 30;7(5):101336. doi: 10.1016/j.jhepr.2025.101336. eCollection 2025 May. JHEP Rep. 2025. PMID: 40248605 Free PMC article.
Focus on hepatocellular carcinoma.
Bruix J, Boix L, Sala M, Llovet JM. Bruix J, et al. Among authors: sala m. Cancer Cell. 2004 Mar;5(3):215-9. doi: 10.1016/s1535-6108(04)00058-3. Cancer Cell. 2004. PMID: 15050913 Free article. Review. No abstract available.
1,400 results